But can I just—you know, one more follow-up to that previous question, which really was that the Minister's drawn our attention to clause 4, that says that "Before issuing a notice … the Director-General must—(a) have regard to the likely therapeutic value of the proposed administration of [a vaccine and the risk]; and (b) be satisfied that the proposed administration … is an appropriate measure to manage the risks associated with the outbreak or spread of COVID-19." I thought it strange that the Minister, despite having said, "Look, I don't have the expertise here.", was quite adamant that if the director-general was going to make a decision, then he could certainly use datasheets from Pfizer, but he couldn't consider the fairly fulsome proceedings of the Food and Drug Administration (FDA) which has been published in the US in the last week. Surely he's not saying this statute as we're currently proposing it would prevent the director-general from having a look at the proceedings of the FDA and the decisions of the Centers for Disease Control and Prevention in the last few days and referring to those, and, if so, do we need to consider whether this legislation is overly prescriptive? I don't think the legislation supports the comments the Minister's made, but, if he could clarify, I think that would be very helpful.